Literature DB >> 35925129

[Functional vascular acrosyndromes].

Peter Klein-Weigel1, Andreas Ruttloff2, Dana König2, Jessica Nielitz2, Julia Steindl2, Oliver Sander3, Jutta G Richter3.   

Abstract

Vascular acrosyndromes are characterized by sparse, uniform clinical manifestations and a variety of possible pathomechanisms. The present article focuses on the functional entities. Raynaud phenomenon is based on cold- or stress-induced vasospasms of acral arteries. It is defined by the color changes of the skin, in the typical case white-blue-red (tricolore). The long fingers are most commonly affected. The etiology is unknown, and the pathophysiology is poorly understood. A distinction is made between primary and a secondary Raynaud phenomenon. The most important underlying diseases include collagenosis, primarily systemic sclerosis, and malignancies; furthermore, medications and drugs may promote vasospasm. Treatment is aimed at preventing or breaking the vasospasm, but has been only partially effective in doing so. Acrocyanosis is a vasospastic dystonic acral disorder that results in permanent reddish-livid discoloration, especially of the hands and feet. Secondary forms occur in collagenosis, malignancies, and myelodysplastic syndromes. The etiology and pathophysiology are virtually unknown. Targeted pharmacological intervention is not possible. Unlike all other vascular acrosyndromes, erythromelalgia is characterized by hyperemia. The primary form is a genetic sodium channelopathy, while secondary forms include malignancies, connective tissue diseases, and myelodysplastic syndromes. The symptoms are often distressing and disabling. Therapy requires a multimodal approach that includes both nonpharmacological and pharmacological strategies. Close interdisciplinary collaboration is essential for the management of this disease.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Acral cyanosis; Circulation disorders, acral; Erythromelalgia; Raynaud disease; Vasospasm

Mesh:

Year:  2022        PMID: 35925129     DOI: 10.1007/s00108-022-01340-w

Source DB:  PubMed          Journal:  Inn Med (Heidelb)        ISSN: 2731-7080


  59 in total

1.  A two-stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon.

Authors:  E Susol; A J MacGregor; J H Barrett; H Wilson; C Black; K Welsh; A Silman; B Ollier; J Worthington
Journal:  Arthritis Rheum       Date:  2000-07

2.  Heritability of Raynaud's phenomenon and vascular responsiveness to cold: a study of adult female twins.

Authors:  L F Cherkas; F M K Williams; L Carter; K Howell; C M Black; T D Spector; A J MacGregor
Journal:  Arthritis Rheum       Date:  2007-04-15

3.  The menstrual cycle and Raynaud's phenomenon.

Authors:  D Greenstein; N Jeffcote; D Ilsley; R C Kester
Journal:  Angiology       Date:  1996-05       Impact factor: 3.619

Review 4.  Functional vascular diseases: Raynaud's syndrome, acrocyanosis and erythromelalgia.

Authors:  H Heidrich
Journal:  Vasa       Date:  2010-02       Impact factor: 1.961

5.  Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

Authors:  H R Maricq; P H Carpentier; M C Weinrich; J E Keil; Y Palesch; C Biro; M Vionnet-Fuasset; M Jiguet; I Valter
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

Review 6.  ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.

Authors:  Jill Belch; Anita Carlizza; Patrick H Carpentier; Joel Constans; Faisel Khan; Jean-Claude Wautrecht; Adriana Visona; Christian Heiss; Marianne Brodeman; Zsolt Pécsvárady; Karel Roztocil; Mary-Paula Colgan; Dragan Vasic; Anders Gottsäter; Beatrice Amann-Vesti; Ali Chraim; Pavel Poredoš; Dan-Mircea Olinic; Juraj Madaric; Sigrid Nikol; Ariane L Herrick; Muriel Sprynger; Peter Klein-Weigel; Franz Hafner; Daniel Staub; Zan Zeman
Journal:  Vasa       Date:  2017-09-12       Impact factor: 1.961

7.  Impaired thermoregulation in Raynaud's phenomenon.

Authors:  D Greenstein; N K Gupta; P Martin; D R Walker; R C Kester
Journal:  Angiology       Date:  1995-07       Impact factor: 3.619

Review 8.  International consensus criteria for the diagnosis of Raynaud's phenomenon.

Authors:  Emanual Maverakis; Forum Patel; Daniel G Kronenberg; Lorinda Chung; David Fiorentino; Yannick Allanore; Serena Guiducci; Roger Hesselstrand; Laura K Hummers; Chris Duong; Bashar Kahaleh; Alexander Macgregor; Marco Matucci-Cerinic; Frank A Wollheim; Maureen D Mayes; M Eric Gershwin
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

Review 9.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

10.  Impact of global warming on Raynaud's phenomenon: a modelling study.

Authors:  Charles Khouri; Matthieu Roustit; Jean-Luc Cracowski
Journal:  F1000Res       Date:  2020-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.